Use of Chinese Herbal Medicines Is Related to a Reduction in Depression Risk Among Patients With Insomnia: A Matched Cohort Study

被引:11
作者
Chiao, Yun-Wen [1 ,2 ]
Livneh, Hanoch [3 ]
Guo, How-Ran [4 ,5 ,6 ]
Chen, Wei-Jen [1 ]
Lu, Ming-Chi [7 ,8 ]
Lin, Miao-Chiu [9 ]
Yeh, Chia-Chou [1 ,10 ]
Tsai, Tzung-Yi [6 ,11 ,12 ]
机构
[1] Buddhist Tzuchi Med Fdn, Dept Chinese Med, Dalin Tzuchi Hosp, Chiayi, Taiwan
[2] Kaohsiung Vet Gen Hosp, Dept Tradit Med, Kaohsiung, Taiwan
[3] Portland State Univ, Rehabil Counseling Program, Portland, OR 97207 USA
[4] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan, Taiwan
[5] Natl Cheng Kung Univ, Occupat Safety Hlth & Med Res Ctr, Tainan, Taiwan
[6] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Coll Med, Tainan, Taiwan
[7] Buddhist Tzuchi Med Fdn, Dalin Tzuchi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan
[8] Tzu Chi Univ, Sch Med, Hualien, Taiwan
[9] Buddhist Tzuchi Med Fdn, Dalin Tzuchi Hosp, Dept Nursing, Chiayi, Taiwan
[10] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan
[11] Buddhist Tzuchi Med Fdn, Dalin Tzuchi Hosp, Dept Med Res, Chiayi, Taiwan
[12] Tzu Chi Univ Sci & Technol, Dept Nursing, Hualien, Taiwan
关键词
insomnia; Chinese herbal medicine; depression; complementary and alternative; cohort study;
D O I
10.3389/fneur.2020.583485
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Subjects with insomnia have a higher risk of depression, thus possibly making them live with serious health conditions. To date, information regarding the effect of Chinese herbal medicines (CHMs), a commonly used complementary and alternative medicine, on depression risk among people with insomnia is still unknown. This study aimed to investigate the effect of CHMs on the risk of depression among individuals with insomnia. Methods: This cohort study used a national health insurance database to identify 68,573 subjects newly diagnosed with insomnia, aged 20-70 years, who received treatment between 1998 and 2010. Using propensity score matching, we randomly selected 26,743 CHMs users and 26,743 non-CHMs users from this sample. All enrollees were followed to the end of 2012 to identify any treatment for depression as the end point. Cox proportional hazards regression was used to compute the adjusted hazard ratio of depression associated with CHMs use. Results: After utilizing the propensity score matching, we randomly selected 26,743 CHMs users and 26,743 non-CHMs users from this sample. During follow up, 3,328 CHMs users and 6,988 non-CHMs users developed depression at incidence rates of 17.24 and 37.97 per 1,000 person-years, respectively. CHMs users had a lower depression risk than the non-CHMs users (adjusted hazard ratio = 0.44; 95% Confidence Interval, 0.42-0.46). The greatest effect was observed for those taking CHMs for more than 2 years. Gegen, Huangqin, Dan-Shen, Beimu, Dahuang, Shegan, Shu-jing-huo-xue-tang, Ge-gen-tang, Shao-yao-gan-cao-tang and Ping wei sx1ce;n were significantly associated with a lower risk of depression. Conclusions: Findings from this study demonstrated that adding CHMs to conventional treatment significantly reduces depression risk among patients with insomnia.
引用
收藏
页数:9
相关论文
共 42 条
[1]   A BDNF AUTOCRINE LOOP IN ADULT SENSORY NEURONS PREVENTS CELL DEATH [J].
ACHESON, A ;
CONOVER, JC ;
FANDL, JP ;
DECHIARA, TM ;
RUSSELL, M ;
THADANI, A ;
SQUINTO, SP ;
YANCOPOULOS, GD ;
LINDSAY, RM .
NATURE, 1995, 374 (6521) :450-453
[2]   Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies [J].
Baglioni, Chiara ;
Battagliese, Gemma ;
Feige, Bernd ;
Spiegelhalder, Kai ;
Nissen, Christoph ;
Voderholzer, Ulrich ;
Lombardo, Caterina ;
Riemann, Dieter .
JOURNAL OF AFFECTIVE DISORDERS, 2011, 135 (1-3) :10-19
[3]   CLINICAL DIAGNOSES IN 216 INSOMNIA PATIENTS USING THE INTERNATIONAL CLASSIFICATION OF SLEEP DISORDERS (ICSD), DSM-IV AND ICD-10 CATEGORIES - A REPORT FROM THE APA/NIMH DSM-IV FIELD TRIAL [J].
BUYSSE, DJ ;
REYNOLDS, CF ;
KUPFER, DJ ;
THORPY, MJ ;
BIXLER, E ;
MANFREDI, R ;
KALES, A ;
VGONTZAS, A ;
STEPANSKI, E ;
ROTH, T ;
HAURI, P ;
MESIANO, D .
SLEEP, 1994, 17 (07) :630-637
[4]   Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002 [J].
Chen, Fang-Pey ;
Jong, Maw-Shiou ;
Chen, Yu-Chun ;
Kung, Yen-Ying ;
Chen, Tzeng-Ji ;
Chen, Fun-Jou ;
Hwang, Shinn-Jang .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2011, 2011
[5]   Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice [J].
Cheng, Jie ;
Dong, Shuqi ;
Yi, Litao ;
Geng, Di ;
Liu, Qing .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 59 :61-67
[6]   α2 adrenergic receptor dysregulation in depressive disorders: Implications for the neurobiology of depression and antidepressant therapy [J].
Cottingham, Christopher ;
Wang, Qin .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2012, 36 (10) :2214-2225
[7]   Comprehensive Meta-Analysis of Excess Mortality in Depression in the General Community Versus Patients With Specific Illnesses [J].
Cuijpers, Pim ;
Vogelzangs, Nicole ;
Twisk, Jos ;
Kleiboer, Annet ;
Li, Juan ;
Penninx, Brenda W. .
AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (04) :453-462
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]   A Meta-Analysis of Cytokines in Major Depression [J].
Dowlati, Yekta ;
Herrmann, Nathan ;
Swardfager, Walter ;
Liu, Helena ;
Sham, Lauren ;
Reim, Elyse K. ;
Lanctot, Krista L. .
BIOLOGICAL PSYCHIATRY, 2010, 67 (05) :446-457
[10]   Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition [J].
Gong, Ping ;
Deng, Fang ;
Zhang, Wei ;
Ji, Jin ;
Liu, Jia ;
Sun, Yinan ;
Hu, Jiayu .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) :4431-4437